LAMISIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Lamisil, and what generic alternatives are available?
Lamisil is a drug marketed by Karo Hlthcare and Novartis and is included in eight NDAs.
The generic ingredient in LAMISIL is terbinafine. There are twenty-seven drug master file entries for this compound. Additional details are available on the terbinafine profile page.
Summary for LAMISIL
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 8 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 91 |
Clinical Trials: | 19 |
Patent Applications: | 4,432 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for LAMISIL |
What excipients (inactive ingredients) are in LAMISIL? | LAMISIL excipients list |
DailyMed Link: | LAMISIL at DailyMed |
Recent Clinical Trials for LAMISIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
The Malassezia Foundation | Early Phase 1 |
Oregon Health and Science University | Early Phase 1 |
Pak Emirates Military Hospital | Phase 3 |
Pharmacology for LAMISIL
Drug Class | Allylamine Antifungal |
Anatomical Therapeutic Chemical (ATC) Classes for LAMISIL
US Patents and Regulatory Information for LAMISIL
Expired US Patents for LAMISIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | LAMISIL | terbinafine hydrochloride | CREAM;TOPICAL | 020192-001 | Dec 30, 1992 | ⤷ Try a Trial | ⤷ Try a Trial |
Karo Hlthcare | LAMISIL | terbinafine | GEL;TOPICAL | 020846-001 | Apr 29, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Karo Hlthcare | LAMISIL | terbinafine | GEL;TOPICAL | 020846-001 | Apr 29, 1998 | ⤷ Try a Trial | ⤷ Try a Trial |
Karo Hlthcare | LAMISIL | terbinafine hydrochloride | CREAM;TOPICAL | 020980-001 | Mar 9, 1999 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | LAMISIL | terbinafine hydrochloride | TABLET;ORAL | 020539-001 | May 10, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Karo Hlthcare | LAMISIL | terbinafine hydrochloride | SOLUTION;TOPICAL | 020749-001 | Oct 17, 1997 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for LAMISIL
See the table below for patents covering LAMISIL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Luxembourg | 88114 | ⤷ Try a Trial | |
Japan | H0415216 | ⤷ Try a Trial | |
Ireland | 70913 | Topical composition containing terbinafine | ⤷ Try a Trial |
Hungary | 223343 | Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására (COMPOSITIONS COMPRISING ALLYLAMINE DERIVATIVES, AND PROCESS FOR THEIR PREPARATION) | ⤷ Try a Trial |
Israel | 101903 | Topical composition containing terbinafine | ⤷ Try a Trial |
European Patent Office | 0515310 | Composition topique de terbinafine (Topical composition of terbinafine) | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for LAMISIL
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0024587 | 93C0136 | Belgium | ⤷ Try a Trial | PRODUCT NAME: TERBINAFINE (250 MG) SOUS FORME DE CHLORHYDRATE (281,25 MG); NAT. REG.: 616 S 201 F3 19911031; FIRST REG.: GB PL 0101/0304 19901003 |
0024587 | SPC/GB93/096 | United Kingdom | ⤷ Try a Trial | SPC/GB93/096, EXPIRES: 20050805 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |